HER-2/neu expression: A major prognostic factor in endometrial cancer
- 1 November 1992
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 47 (2), 179-185
- https://doi.org/10.1016/0090-8258(92)90103-p
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cancer statistics, 1992CA: A Cancer Journal for Clinicians, 1992
- Oncogene alterations in endometrial carcinomaGynecologic Oncology, 1990
- Oncogenes, Growth Factors, and Signal TransductionNew England Journal of Medicine, 1989
- Flow cytometric DNA analysis of stage I endometrial carcinomaGynecologic Oncology, 1989
- An immunohistochemical and in situ hybridization study of c‐myc and c‐erbB‐2 expression in primary human breast carcinomasThe Journal of Pathology, 1989
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptorNature, 1986
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958